The FDA will allow two biotechnology companies to run clinical trials: United Therapeutics and eGenesis. United Therapeutics Corporation will start with six patients but could grow its trial to include up to 50 individuals, while eGenesis plans to begin with three patients.

The research offers hope to tens of thousands of patients with kidney failure who are on a long waiting list for an organ transplant.

The U.S. Food and Drug Administration has approved the first-ever clinical trials testing pig kidney transplants in people with kidney failure, marking a major step forward in cross-species transplantation.

The first clinical trials using organs from genetically modified pigs offer hope to patients with kidney failure, who face a long wait for human organ transplants.

Towana Looney, a woman from Alabama who last year became the third person to undergo a pig kidney transplant, is reportedly still recovering well after her surgery. Having now passed two months since the operation,

Two US biotech companies say the Food and Drug Administration has cleared them to conduct clinical trials of their gene-edited pig kidneys for human transplants.

The United States Food and Drug Administration , in a historic move, allowed the beginning of clinical trials for pig kidney transplants in humans.According to HealthDay, the FDA has approved the beginning of the first-ever clinical trials

United Therapeutics has scored a regulatory green light to start clinical trials for its genetically modified pig kidneys to be transplanted into humans. It's as significant for the medical community as it is for the business.